Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05604222 · ClinicalTrials.gov registry record · Phase 4
Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
A Phase 4 study of Nocturia and Urgency Urinary Incontinence, sponsored by Shachi Tyagi.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05604222 is a Phase 4 study of Nocturia and Urgency Urinary Incontinence that is actively recruiting participants, run by Shachi Tyagi. The registered enrollment target is 120 participants, below the 303-participant average among 9 other Nocturia trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05604222, a Phase 4 study of Nocturia and Urgency Urinary Incontinence, is actively recruiting participants, sponsored by Shachi Tyagi.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Urgency urinary incontinence (UUI) is common in older people and vastly reduces quality of life, yet the cause and mechanism of disease are not well understood. This study will investigate the role of adding behavioral sleep intervention to the standard pharmacotherapy in treatment of UUI among older adults, and the brain mechanisms involved in continence by evaluating brain changes. This will expand the current knowledge of how the sleep affects bladder control, and better characterize the brain mechanisms in maintaining continence.
Conditions Studied
Interventions
- DRUG Mirabegron 50 MG
- BEHAVIORAL Brief Behavioral Treatment for Insomnia
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-03-05 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05604222
The ClinicalTrials.gov registry entry for NCT05604222 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 9 other Nocturia trials with a reported enrollment target (60% lower). The listed sponsor is Shachi Tyagi, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nocturia appearing as the primary indexed condition, and to 2 interventions - of which Mirabegron 50 MG is the first listed.
NCT05604222 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05604222 about?
NCT05604222 is a clinical study titled "Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women". Urgency urinary incontinence (UUI) is common in older people and vastly reduces quality of life, yet the cause and mechanism of disease are not well understood. This study will investigate the role of adding behavioral sleep intervention to the standard pharmacotherapy in treatment of UUI among olde...
What is the current status of trial NCT05604222?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2023-03-05. Estimated completion is 2027-03-31.
What conditions does trial NCT05604222 study?
This clinical trial studies the following conditions: Nocturia, Urgency Urinary Incontinence.
What interventions are being tested in trial NCT05604222?
The interventions under investigation include: Mirabegron 50 MG (DRUG), Brief Behavioral Treatment for Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT05604222?
This trial is sponsored by Shachi Tyagi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05604222 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nocturia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
RECRUITING · Phase 4
-
A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia
COMPLETED · Phase 4
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Multi-center Trial to Improve Nocturia and Sleep in Older Adults
RECRUITING · NA
-
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
RECRUITING · NA
-
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.